VIAF

Virtual International Authority File

Search

Leader 00000nz a2200037n 45 0
001 WKP|Q43154419 (VIAF cluster) (Authority/Source Record)
003 WKP
005 20241020233025.0
008 241020nneanz||abbn n and d
035 ‎‡a (WKP)Q43154419‏
024 ‎‡a 0000-0002-1153-6025‏ ‎‡2 orcid‏
024 ‎‡a 7003482297‏ ‎‡2 scopus‏
035 ‎‡a (OCoLC)Q43154419‏
100 0 ‎‡a Jose A Garcia-Sanz‏ ‎‡9 sl‏
375 ‎‡a 1‏ ‎‡2 iso5218‏
400 0 ‎‡a Jose A Garcia-Sanz‏ ‎‡c researcher‏ ‎‡9 en‏
400 0 ‎‡a Jose A Garcia-Sanz‏ ‎‡c wetenschapper‏ ‎‡9 nl‏
400 0 ‎‡a Jose A Garcia-Sanz‏ ‎‡c investigador‏ ‎‡9 es‏
400 0 ‎‡a Jose A Garcia-Sanz‏ ‎‡c investigador‏ ‎‡9 ast‏
670 ‎‡a Author's 11PS04 is a new chemical entity identified by microRNA-based biosensing with promising therapeutic potential against cancer stem cells‏
670 ‎‡a Author's 92R Monoclonal Antibody Inhibits Human CCR9+ Leukemia Cells Growth in NSG Mice Xenografts.‏
670 ‎‡a Author's Activation of RANKL-induced osteoclasts and memory T lymphocytes by Porphyromonas gingivalis is serotype dependant.‏
670 ‎‡a Author's An endogenous hybrid mRNA encodes TWE-PRIL, a functional cell surface TWEAK-APRIL fusion protein‏
670 ‎‡a Author's Cell therapy with allogenic canine periodontal ligament-derived cells in periodontal regeneration of critical size defects.‏
670 ‎‡a Author's Characterization of novel monoclonal antibodies able to identify neurogenic niches and arrest neurosphere proliferation and differentiation.‏
670 ‎‡a Author's Chemokine receptor-specific antibodies in cancer immunotherapy: achievements and challenges‏
670 ‎‡a Author's Comparison of periodontal ligament and gingiva-derived mesenchymal stem cells for regenerative therapies‏
670 ‎‡a Author's Detection of mouse endogenous type B astrocytes migrating towards brain lesions.‏
670 ‎‡a Author's Differential cytokine expression by human dendritic cells in response to different Porphyromonas gingivalis capsular serotypes.‏
670 ‎‡a Author's Distinct human T-lymphocyte responses triggered by Porphyromonas gingivalis capsular serotypes‏
670 ‎‡a Author's Editorial: Is the Recent Burst of Therapeutic Anti-tumor Antibodies the Tip of an Iceberg?‏
670 ‎‡a Author's Expression of proinflammatory cytokines in osteoarthritis of the temporomandibular joint.‏
670 ‎‡a Author's Global and specific translational control by rapamycin in T cells uncovered by microarrays and proteomics‏
670 ‎‡a Author's Insights of the brain damage response using antibodies identifying surface antigens on neural stem cells and neuroblasts‏
670 ‎‡a Author's Intrinsic cues and hormones control mouse mammary epithelial tree size.‏
670 ‎‡a Author's Isolation of polysome-bound mRNA from solid tissues amenable for RT-PCR and profiling experiments.‏
670 ‎‡a Author's Live imaging of mouse endogenous neural progenitors migrating in response to an induced tumor.‏
670 ‎‡a Author's New Strategies Using Antibody Combinations to Increase Cancer Treatment Effectiveness‏
670 ‎‡a Author's Regulation of mRNA expression in macrophages after Yersinia enterocolitica infection. Role of different Yop effectors.‏
670 ‎‡a Author's Sfrp3 modulates stromal-epithelial crosstalk during mammary gland development by regulating Wnt levels‏
670 ‎‡a Author's Targeting neural stem cells with titanium dioxide nanoparticles coupled to specific monoclonal antibodies‏
670 ‎‡a Author's The mouse male germ cell-specific gene Tpx-1: molecular structure, mode of expression in spermatogenesis, and sequence similarity to two non-mammalian genes‏
670 ‎‡a Author's Transcriptional and translational control of TNF- Alpha gene expression in human monocytes by major histocompatibility complex class II ligands‏
670 ‎‡a Author's Translation control: bridging the gap between genomics and proteomics?‏
670 ‎‡a Author's Variability in the response of human dendritic cells stimulated with Porphyromonas gingivalis or Aggregatibacter actinomycetemcomitans.‏
670 ‎‡a Author's Will a mAb-Based Immunotherapy Directed against Cancer Stem Cells Be Feasible?‏
909 ‎‡a (orcid) 0000000211536025‏ ‎‡9 1‏
909 ‎‡a (scopus) 7003482297‏ ‎‡9 1‏
919 ‎‡a chemokinereceptorspecificantibodiesincancerimmunotherapyachievementsandchallenges‏ ‎‡A Chemokine receptor-specific antibodies in cancer immunotherapy: achievements and challenges‏ ‎‡9 1‏
919 ‎‡a comparisonofperiodontalligamentandgingivaderivedmesenchymalstemcellsforregenerativetherapies‏ ‎‡A Comparison of periodontal ligament and gingiva-derived mesenchymal stem cells for regenerative therapies‏ ‎‡9 1‏
919 ‎‡a detectionofmouseendogenoustypebastrocytesmigratingtowardsbrainlesions‏ ‎‡A Detection of mouse endogenous type B astrocytes migrating towards brain lesions.‏ ‎‡9 1‏
919 ‎‡a differentialcytokineexpressionbyhumandendriticcellsinresponsetodifferentporphyromonasgingivaliscapsularserotypes‏ ‎‡A Differential cytokine expression by human dendritic cells in response to different Porphyromonas gingivalis capsular serotypes.‏ ‎‡9 1‏
919 ‎‡a distincthumantlymphocyteresponsestriggeredbyporphyromonasgingivaliscapsularserotypes‏ ‎‡A Distinct human T-lymphocyte responses triggered by Porphyromonas gingivalis capsular serotypes‏ ‎‡9 1‏
919 ‎‡a editorialistherecentburstoftherapeuticantitumorantibodiesthetipofaniceberg‏ ‎‡A Editorial: Is the Recent Burst of Therapeutic Anti-tumor Antibodies the Tip of an Iceberg?‏ ‎‡9 1‏
919 ‎‡a expressionofproinflammatorycytokinesinosteoarthritisofthetemporomandibularjoint‏ ‎‡A Expression of proinflammatory cytokines in osteoarthritis of the temporomandibular joint.‏ ‎‡9 1‏
919 ‎‡a globalandspecifictranslationalcontrolbyrapamycinintcellsuncoveredbymicroarraysandproteomics‏ ‎‡A Global and specific translational control by rapamycin in T cells uncovered by microarrays and proteomics‏ ‎‡9 1‏
919 ‎‡a insightsofthebraindamageresponseusingantibodiesidentifyingsurfaceantigensonneuralstemcellsandneuroblasts‏ ‎‡A Insights of the brain damage response using antibodies identifying surface antigens on neural stem cells and neuroblasts‏ ‎‡9 1‏
919 ‎‡a intrinsiccuesandhormonescontrolmousemammaryepithelialtreesize‏ ‎‡A Intrinsic cues and hormones control mouse mammary epithelial tree size.‏ ‎‡9 1‏
919 ‎‡a isolationofpolysomeboundmrnafromsolidtissuesamenableforrtpcrandprofilingexperiments‏ ‎‡A Isolation of polysome-bound mRNA from solid tissues amenable for RT-PCR and profiling experiments.‏ ‎‡9 1‏
919 ‎‡a liveimagingofmouseendogenousneuralprogenitorsmigratinginresponsetoaninducedtumor‏ ‎‡A Live imaging of mouse endogenous neural progenitors migrating in response to an induced tumor.‏ ‎‡9 1‏
919 ‎‡a newstrategiesusingantibodycombinationstoincreasecancertreatmenteffectiveness‏ ‎‡A New Strategies Using Antibody Combinations to Increase Cancer Treatment Effectiveness‏ ‎‡9 1‏
919 ‎‡a regulationofmrnaexpressioninmacrophagesafteryersiniaenterocoliticainfectionroleofdifferentyopeffectors‏ ‎‡A Regulation of mRNA expression in macrophages after Yersinia enterocolitica infection. Role of different Yop effectors.‏ ‎‡9 1‏
919 ‎‡a sfrp3modulatesstromalepithelialcrosstalkduringmammaryglanddevelopmentbyregulatingwntlevels‏ ‎‡A Sfrp3 modulates stromal-epithelial crosstalk during mammary gland development by regulating Wnt levels‏ ‎‡9 1‏
919 ‎‡a targetingneuralstemcellswithtitaniumdioxidenanoparticlescoupledtospecificmonoclonalantibodies‏ ‎‡A Targeting neural stem cells with titanium dioxide nanoparticles coupled to specific monoclonal antibodies‏ ‎‡9 1‏
919 ‎‡a mousemalegermcellspecificgenetpx1molecularstructuremodeofexpressioninspermatogenesisandsequencesimilarityto2nonmammaliangenes‏ ‎‡A The mouse male germ cell-specific gene Tpx-1: molecular structure, mode of expression in spermatogenesis, and sequence similarity to two non-mammalian genes‏ ‎‡9 1‏
919 ‎‡a transcriptionalandtranslationalcontroloftnf Alpha geneexpressioninhumanmonocytesbymajorhistocompatibilitycomplexclass2ligands‏ ‎‡A Transcriptional and translational control of TNF- Alpha gene expression in human monocytes by major histocompatibility complex class II ligands‏ ‎‡9 1‏
919 ‎‡a 11ps04isanewchemicalentityidentifiedbymicrornabasedbiosensingwithpromisingtherapeuticpotentialagainstcancerstemcells‏ ‎‡A 11PS04 is a new chemical entity identified by microRNA-based biosensing with promising therapeutic potential against cancer stem cells‏ ‎‡9 1‏
919 ‎‡a 92rmonoclonalantibodyinhibitshumanccr9+leukemiacellsgrowthinnsgmicexenografts‏ ‎‡A 92R Monoclonal Antibody Inhibits Human CCR9+ Leukemia Cells Growth in NSG Mice Xenografts.‏ ‎‡9 1‏
919 ‎‡a activationofranklinducedosteoclastsandmemorytlymphocytesbyporphyromonasgingivalisisserotypedependant‏ ‎‡A Activation of RANKL-induced osteoclasts and memory T lymphocytes by Porphyromonas gingivalis is serotype dependant.‏ ‎‡9 1‏
919 ‎‡a endogenoushybridmrnaencodestweprilafunctionalcellsurfacetweakaprilfusionprotein‏ ‎‡A An endogenous hybrid mRNA encodes TWE-PRIL, a functional cell surface TWEAK-APRIL fusion protein‏ ‎‡9 1‏
919 ‎‡a celltherapywithallogeniccanineperiodontalligamentderivedcellsinperiodontalregenerationofcriticalsizedefects‏ ‎‡A Cell therapy with allogenic canine periodontal ligament-derived cells in periodontal regeneration of critical size defects.‏ ‎‡9 1‏
919 ‎‡a characterizationofnovelmonoclonalantibodiesabletoidentifyneurogenicnichesandarrestneurosphereproliferationanddifferentiation‏ ‎‡A Characterization of novel monoclonal antibodies able to identify neurogenic niches and arrest neurosphere proliferation and differentiation.‏ ‎‡9 1‏
919 ‎‡a willamabbasedimmunotherapydirectedagainstcancerstemcellsbefeasible‏ ‎‡A Will a mAb-Based Immunotherapy Directed against Cancer Stem Cells Be Feasible?‏ ‎‡9 1‏
919 ‎‡a variabilityintheresponseofhumandendriticcellsstimulatedwithporphyromonasgingivalisoraggregatibacteractinomycetemcomitans‏ ‎‡A Variability in the response of human dendritic cells stimulated with Porphyromonas gingivalis or Aggregatibacter actinomycetemcomitans.‏ ‎‡9 1‏
919 ‎‡a translationcontrolbridgingthegapbetweengenomicsandproteomics‏ ‎‡A Translation control: bridging the gap between genomics and proteomics?‏ ‎‡9 1‏
946 ‎‡a b‏ ‎‡9 1‏
996 ‎‡2 NUKAT|n 2018168727
996 ‎‡2 SUDOC|219921024
996 ‎‡2 DNB|1157160263
996 ‎‡2 BNE|XX1376806
996 ‎‡2 ISNI|0000000060941727
996 ‎‡2 LC|ns2012005065
996 ‎‡2 DNB|1016550731
996 ‎‡2 BNE|XX1541384
996 ‎‡2 BNC|981058595922006706
996 ‎‡2 BNE|XX1000764
996 ‎‡2 BNE|XX903217
996 ‎‡2 BNC|981058524094406706
996 ‎‡2 SUDOC|231839669
996 ‎‡2 BNE|XX1162771
996 ‎‡2 BNF|17810035
996 ‎‡2 DNB|1030555885
996 ‎‡2 BNE|XX1080911
996 ‎‡2 DNB|1229450971
996 ‎‡2 BNC|981058514076306706
996 ‎‡2 RERO|A005749933
996 ‎‡2 SUDOC|221545360
996 ‎‡2 LC|n 2004140891
996 ‎‡2 BNF|15913672
996 ‎‡2 BNC|981058514070806706
996 ‎‡2 ARBABN|000057023
996 ‎‡2 ISNI|0000000432793236
996 ‎‡2 LC|n 2007000386
996 ‎‡2 NUKAT|n 2010077126
996 ‎‡2 BNE|XX1691470
996 ‎‡2 BNE|XX983952
996 ‎‡2 BNE|XX1316824
996 ‎‡2 NTA|152427724
996 ‎‡2 BNE|XX1081958
996 ‎‡2 SUDOC|255163894
996 ‎‡2 BNE|XX820581
996 ‎‡2 LC|no2011011454
996 ‎‡2 ISNI|0000000059351922
996 ‎‡2 LC|no2001003595
996 ‎‡2 RERO|A010951224
996 ‎‡2 ISNI|0000000061011847
996 ‎‡2 DNB|100390315
996 ‎‡2 SUDOC|097649937
996 ‎‡2 BLBNB|001476448
996 ‎‡2 BNE|XX5078509
996 ‎‡2 LC|no2018102248
996 ‎‡2 BNC|981058611027106706
996 ‎‡2 ISNI|0000000073260875
996 ‎‡2 LC|n 79004179
996 ‎‡2 PTBNP|1478366
996 ‎‡2 LC|n 2007001652
996 ‎‡2 ISNI|0000000059269777
996 ‎‡2 ISNI|0000000063021061
996 ‎‡2 ISNI|0000000428292973
996 ‎‡2 BNC|981058509052106706
996 ‎‡2 ISNI|0000000442476541
996 ‎‡2 BNE|XX1723342
996 ‎‡2 NYNYRILM|54783
996 ‎‡2 NII|DA10091283
996 ‎‡2 ISNI|0000000059743053
996 ‎‡2 DNB|1057127507
996 ‎‡2 NTA|39092850X
996 ‎‡2 NTA|419576061
996 ‎‡2 BNC|981058581051006706
996 ‎‡2 BNE|XX1151521
996 ‎‡2 BNE|XX948656
996 ‎‡2 J9U|987007398274905171
996 ‎‡2 RERO|A006277528
996 ‎‡2 LC|nb2007008254
996 ‎‡2 ISNI|000000005945960X
996 ‎‡2 SUDOC|122920562
996 ‎‡2 BNE|XX1091470
996 ‎‡2 SUDOC|115322337
996 ‎‡2 BNF|17002143
996 ‎‡2 ISNI|0000000081454821
996 ‎‡2 SUDOC|074159852
996 ‎‡2 ISNI|0000000059999534
996 ‎‡2 LC|n 92065589
996 ‎‡2 ISNI|0000000118629614
996 ‎‡2 BNC|981058517868106706
996 ‎‡2 BNF|15559462
996 ‎‡2 ISNI|0000000059570578
996 ‎‡2 RERO|A024377408
996 ‎‡2 SUDOC|272724572
996 ‎‡2 BNE|XX900209
996 ‎‡2 LC|n 2003100424
996 ‎‡2 BNE|XX1754081
996 ‎‡2 BNE|XX5617542
996 ‎‡2 BNE|XX1011686
996 ‎‡2 LC|no 98022297
996 ‎‡2 BNE|XX1167674
996 ‎‡2 BNE|XX956197
996 ‎‡2 PTBNP|1724547
996 ‎‡2 DNB|171802675
996 ‎‡2 PTBNP|1657577
996 ‎‡2 DNB|1159087326
996 ‎‡2 BNC|981058522366006706
996 ‎‡2 ISNI|0000000398551558
996 ‎‡2 ISNI|0000000116560270
996 ‎‡2 BNE|XX883175
996 ‎‡2 LC|n 2019026610
996 ‎‡2 BNE|XX981647
996 ‎‡2 BNE|XX819899
996 ‎‡2 DNB|1057470880
996 ‎‡2 ISNI|0000000079789358
996 ‎‡2 ISNI|0000000059559934
996 ‎‡2 BNC|981058512073206706
996 ‎‡2 LC|n 88135613
996 ‎‡2 ISNI|0000000080484383
996 ‎‡2 ISNI|0000000059478253
996 ‎‡2 BNE|XX847580
996 ‎‡2 BNE|XX1733317
996 ‎‡2 ISNI|0000000044585443
996 ‎‡2 ISNI|0000000059419632
996 ‎‡2 BNF|16189912
996 ‎‡2 LC|nr 99012426
996 ‎‡2 BNE|XX1065176
996 ‎‡2 ISNI|0000000486637730
996 ‎‡2 BNE|XX5490977
996 ‎‡2 ISNI|0000000059591889
996 ‎‡2 SUDOC|060965606
996 ‎‡2 BNC|981060957489806706
996 ‎‡2 ICCU|CFIV174281
996 ‎‡2 BNE|XX1288278
996 ‎‡2 BNE|XX1066559
996 ‎‡2 DNB|142880094
996 ‎‡2 SUDOC|111895251
996 ‎‡2 DNB|1057580635
996 ‎‡2 BNE|XX1046501
996 ‎‡2 SUDOC|261640895
996 ‎‡2 PTBNP|1672566
996 ‎‡2 ISNI|0000000060722874
996 ‎‡2 SUDOC|088394956
996 ‎‡2 LC|n 82081074
996 ‎‡2 BNF|15508965
996 ‎‡2 LC|nr 95034634
996 ‎‡2 LC|n 88613026
996 ‎‡2 BNE|XX1631345
996 ‎‡2 ISNI|0000000071053805
996 ‎‡2 BNE|XX1194325
996 ‎‡2 SUDOC|252777948
996 ‎‡2 NKC|vse20211131706
996 ‎‡2 BNE|XX919646
996 ‎‡2 ISNI|0000000113312431
996 ‎‡2 ISNI|0000000108086433
996 ‎‡2 SUDOC|263799166
996 ‎‡2 ISNI|0000000027720447
996 ‎‡2 ISNI|0000000059355798
996 ‎‡2 RERO|A003785765
996 ‎‡2 ISNI|0000000060038183
996 ‎‡2 BNF|17754770
996 ‎‡2 CAOONL|ncf11956177
996 ‎‡2 ISNI|0000000104449575
996 ‎‡2 ISNI|0000000069295645
996 ‎‡2 LC|n 2024034004
996 ‎‡2 NYNYRILM|89426
996 ‎‡2 BNE|XX5859955
996 ‎‡2 BNE|XX1119066
996 ‎‡2 LC|n 80148717
996 ‎‡2 BNF|14553086
996 ‎‡2 DNB|1337375160
996 ‎‡2 BNC|981058512862206706
996 ‎‡2 BNE|XX1280644
996 ‎‡2 BNE|XX976578
996 ‎‡2 BAV|495_269984
996 ‎‡2 RERO|A003076568
996 ‎‡2 BIBSYS|1581514959145
996 ‎‡2 BNE|XX1174057
996 ‎‡2 SUDOC|02915412X
996 ‎‡2 LC|n 99901288
996 ‎‡2 NUKAT|n 96402377
996 ‎‡2 BNF|16209842
996 ‎‡2 J9U|987007422421305171
996 ‎‡2 SUDOC|159001366
996 ‎‡2 BNE|XX1726894
996 ‎‡2 BNE|XX5747303
996 ‎‡2 BNE|XX860250
996 ‎‡2 DNB|1169456766
996 ‎‡2 BIBSYS|1560455411122
996 ‎‡2 BNE|XX1330613
996 ‎‡2 BNE|XX5158579
996 ‎‡2 DNB|1053747292
996 ‎‡2 BNF|12450161
996 ‎‡2 BNE|XX864727
996 ‎‡2 NUKAT|n 2006089373
996 ‎‡2 BNE|XX1697947
996 ‎‡2 PLWABN|9810623746505606
996 ‎‡2 BIBSYS|10071732
996 ‎‡2 ISNI|0000000059496806
996 ‎‡2 BNF|13605892
996 ‎‡2 BNE|XX1587997
996 ‎‡2 BNE|XX1108534
996 ‎‡2 RERO|A003366780
996 ‎‡2 DNB|1053275722
996 ‎‡2 SUDOC|115671412
996 ‎‡2 BNE|XX1247367
996 ‎‡2 BNE|XX6290811
996 ‎‡2 BNE|XX900475
996 ‎‡2 BNC|981058512973006706
996 ‎‡2 BNE|XX1516114
996 ‎‡2 JPG|500223015
996 ‎‡2 NII|DA02043296
996 ‎‡2 NTA|327685522
996 ‎‡2 LC|n 97029722
996 ‎‡2 SUDOC|094651906
996 ‎‡2 LC|n 95076665
996 ‎‡2 BNE|XX1743218
996 ‎‡2 BNE|XX5603849
996 ‎‡2 SUDOC|195767942
996 ‎‡2 BNE|XX1001224
996 ‎‡2 BNE|XX877124
996 ‎‡2 BNE|XX1651110
996 ‎‡2 BNE|XX899311
996 ‎‡2 PTBNP|1779516
996 ‎‡2 BNE|XX867983
996 ‎‡2 LC|n 97030217
996 ‎‡2 BIBSYS|1614095182880
996 ‎‡2 BLBNB|000215371
996 ‎‡2 LC|n 95063853
996 ‎‡2 ISNI|0000000002487319
996 ‎‡2 NUKAT|n 2009124275
996 ‎‡2 BNE|XX1617034
996 ‎‡2 SUDOC|255415613
996 ‎‡2 DBC|87097968903645
996 ‎‡2 LC|n 2004108572
996 ‎‡2 NTA|155024019
996 ‎‡2 BNC|981060745369206706
996 ‎‡2 DNB|1159087318
996 ‎‡2 BNE|XX1508932
996 ‎‡2 ISNI|0000000059984404
996 ‎‡2 BNE|XX961964
996 ‎‡2 DNB|1056250550
996 ‎‡2 BNE|XX995529
996 ‎‡2 NYNYRILM|59589
996 ‎‡2 BNE|XX953011
996 ‎‡2 BNE|XX1042244
996 ‎‡2 BNF|16256122
996 ‎‡2 DNB|1057084328
996 ‎‡2 BNF|12083887
996 ‎‡2 LC|n 92043299
996 ‎‡2 BIBSYS|90747761
996 ‎‡2 RERO|A003567396
996 ‎‡2 BNE|XX995801
996 ‎‡2 BNE|XX5433805
996 ‎‡2 SUDOC|06722959X
996 ‎‡2 DNB|1057206830
996 ‎‡2 ISNI|0000000059850270
996 ‎‡2 ISNI|0000000024133669
996 ‎‡2 DNB|1256395781
996 ‎‡2 LC|no2010106862
996 ‎‡2 BNE|XX1183493
997 ‎‡a 0 0 lived 0 0‏ ‎‡9 1‏